Discontinuation of Methotrexate in Rheumatoid Arthritis Patients Achieving Clinical Remission by Treatment With Upadacitinib Plus Methotrexate
Phase 3
Recruiting
- Conditions
- Rheumatoid ArthritisJAK InhibitorBiomarkerMusculoskeletal Ultrasound
- Interventions
- First Posted Date
- 2021-11-16
- Last Posted Date
- 2021-12-08
- Lead Sponsor
- Atsushi Kawakami
- Target Recruit Count
- 155
- Registration Number
- NCT05121298
- Locations
- 🇯🇵
Nagasaki University Hospital, Nagasaki, Japan
Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
Phase 3
- Conditions
- Musculoskeletal UltrasoundBiomarkerRheumatoid ArthritisIL-6 InhibitorJAK Inhibitor
- Interventions
- First Posted Date
- 2021-10-22
- Last Posted Date
- 2021-11-01
- Lead Sponsor
- Atsushi Kawakami
- Target Recruit Count
- 400
- Registration Number
- NCT05090410
- Locations
- 🇯🇵
Nagasaki University Hospital, Nagasaki, Japan
© Copyright 2025. All Rights Reserved by MedPath